Cambridge Polymer Group has been a trusted partner for orthopaedic manufacturers and OEMs since the early 2000s. We help orthopaedic device teams de‑risk materials decisions for joint replacement, spine, trauma, and sports medicine, from early formulation through regulatory submission and post‑market investigation.

Orthopaedic Devices and Materials We Support

Orthopaedic implants and instruments must survive years of cyclic loading and articulation while maintaining stability under sterilization, cleaning, and storage. Our team routinely supports:

  • Total joint arthroplasty (hips, knees, shoulders) using UHMWPE, crosslinked UHMWPE, advanced antioxidant‑stabilized formulations and other thermoplastics.
  • Spine devices and motion‑preserving concepts, including annulus fibrosus and nucleus pulposus hydrogels and spinal implants.
  • Trauma and sports medicine implants that combine metals, polymers, and bone cements.
  • Cartilage repair and soft‑tissue devices that rely on load‑bearing and cartilage friendly materials, such as hydrogels and other novel biomaterials.

Orthopaedic teams come to us when they need to qualify new UHMWPE or bone cement systems, explore synthetic cartilage or disc concepts, investigate unexpected oxidation or wear, or justify material choices to regulators.

What Orthopaedic Teams Gain by Working with CPG

Our orthopaedic clients look for clear, decision‑ready outcomes, not just test results. Working with CPG helps you:

  • Reduce late‑stage risk by linking wear, oxidation, aging, and mechanical testing directly to your clinical use scenarios.
  • Get faster, defensible root‑cause answers for in vivo issues such as surface damage, abnormal oxidation , bone cement problems, failed bearings, or process‑induced defects.
  • Understand manufacturing issues early and efficiently.
  • Strengthen 510(k), PMA, and De Novo filings with 10993‑18‑aligned chemical characterization, biocompatibility support, and experienced regulatory submission consulting.

A typical first step is a brief consult to review your device, materials, and open questions, followed by a focused proposal with scope, methods, and timelines aligned to your development stage or device stage needs.

Core Services for Orthopaedic Programs

We organize our orthopaedic testing and consulting services around the questions R&D, materials, and regulatory leaders actually ask.

Is This the Right Material and Formulation?

When you are deciding between materials or tuning a formulation, we support you with:

  • Material Selection & Material Development – Mapping clinical and regulatory requirements to UHMWPE, PCL, ABS, PEEK, hydrogels, bone cements, adhesives, and other orthopedic materials.
  • Biomedical Materials & Research and Development – Iterating on formulations, additives, and processing to achieve target properties for articulating and load‑bearing applications, with material validation against internal and external requirements.
  • Molecular Weight Analysis – Using GPC and related techniques to track UHMWPE, PCL, and other polymers through processing and aging, verify resin consistency, and satisfy residual monomer and molecular-weight related requirements.
  • Morphology and Thermal Analysis – Evaluating morphology, melting temperature, and crystallinity using DSC and complementary methods to link microstructure to wear, fatigue, and crack‑propagation behavior.

Will It Last and Behave as Intended Over Time?

To ensure long‑term performance under realistic loads and environments, we provide:

  • Mechanical Analysis – Wear, fatigue, creep, and other mechanical tests aligned with orthopedic load conditions for joints, spine, and trauma devices.
  • Accelerated Aging & Sterilization Compatibility – Designing accelerated aging studies, including oxygen bomb and ASTM F2003‑style oxidative protocols, then evaluating how sterilization and storage affect material and device performance.
  • Antioxidants & OIT – Quantifying antioxidant content and performance in UHMWPE and related materials, and interpreting results in the context of long‑term oxidation resistance.

Where appropriate, we reference and apply standards such as ASTM D2756, ASTM D638, ASTM F2003, ASTM F2101 to keep your testing aligned with industry practice for articulating components.

Is It Safe and Ready for Regulatory Review?

When you are preparing to submit or respond to regulators, we support you with:

  • Biocompatibility & 10993‑18 Chemical Characterization – Extractables/leachables and broader chemical profiling, plus biological risk assessment (BRA) and biological evaluation plans for orthopedic implants and materials.
  • Chemical Characterization for Orthopedic Devices – Focused strategies for implants, bone cements, and hydrogels that align with current expectations for new or modified materials.
  • Regulatory Submissions Support – Data packages and technical narratives that support 510(k)s, PMAs, De Novos, and responses to questions about materials, degradation, equivalence, and test methods.

What Went Wrong—and How Do We Fix It?

If something fails in testing, manufacturing, or post‑market, we help you understand why and what to do next:

  • Root Cause/Failure Analysis – Investigations of wear anomalies, oxidation gradients, surface damage, bone cement defects, and other failure modes in orthopedic devices, using SEM fractography, FTIR, DSC, crystallinity analysis, and chemical characterization to link observed damage to fatigue crack propagation, processing, or environmental exposure.
  • Manufacturing Support – Connecting process parameters to resulting material behavior, helping you adjust and document process changes that prevent recurrence and satisfy internal and external stakeholders.

Whether you are troubleshooting a failed bearing or a broader pattern of surface changes, we translate analytical findings into clear, actionable recommendations.

Load‑bearing Hydrogels and Synthetic Cartilage

For teams developing synthetic cartilage, disc replacements, or soft‑tissue scaffolds, CPG offers a combination of R&D and testing capabilities:

  • Development of load‑bearing hydrogels tuned to cartilage‑like mechanical and tribological properties for joint and spine applications.
  • Utilization of proprietary hydrogel and aligned‑polymer technologies described in our patents for cartilage, spinal disc, and soft‑tissue repair.
  • Custom in vitro device testing and synthetic tissue phantoms that provide realistic, repeatable environments for evaluating implant performance.

This support helps you move from early‑stage hydrogel concepts to testable prototypes with a clear path to generating data suitable for regulatory review.

Thought Leadership, Publications, and Patents

Our orthopaedic work is grounded in a long history of external validation:

  • Peer‑reviewed publications on UHMWPE material properties, oxidation measurement, accelerated aging, hyaluronic acid rheology, and hydrogel behavior relevant to orthopedic devices.
  • Blog articles on topics such as FDA regulation of new UHMWPE components, molecular weight characterization to assess aging in UHMWPE, additive manufacturing of medical devices, and PEEK crystallinity.
  • A patent portfolio covering crosslinked UHMWPE with reduced free radicals, systems to improve cement fixation, hydrogel systems for cartilage and disc applications, and aligned polymer structures for tendon‑ and ligament‑like scaffolds.

These resources give your internal teams confidence that our recommendations reflect current science, standards, and regulatory experience, not just isolated test results.

How to Start Working with Cambridge Polymer Group

Our orthopaedic specialists act as an extension of your R&D, quality, and regulatory teams. Whether you are:

  • Seeking a second source for your material.
  • Developing a new material concept.
  • Qualifying a new formulation.
  • Investigating unexpected oxidation, wear, or manufacturing‑related failures.
  • Developing a novel hydrogel‑based cartilage or disc device.
  • Preparing a 510(k), PMA, or De Novo with complex materials and degradation questions.

We can scope a focused engagement that delivers decision‑ready data and clear, defensible narratives. To explore how our orthopedic materials and testing expertise can support your joint replacement, spine, trauma, or soft‑tissue device, contact Cambridge Polymer Group to schedule an initial discussion and outline a tailored plan.